ZBH
Zimmer Biomet Holdings Inc
NYSE: ZBH · HEALTHCARE · MEDICAL DEVICES
$80.07
-3.30% today
Updated 2026-04-29
Market cap
$15.50B
P/E ratio
20.74
P/S ratio
1.84x
EPS (TTM)
$3.86
Dividend yield
1.16%
52W range
$80 – $107
Volume
2.2M
Zimmer Biomet Holdings Inc (ZBH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.04B | $1.08B | $1.04B | $1.12B | $1.19B | $1.18B | $1.15B | $963.10M | $1.06B | $849.80M | $1.63B | $1.58B | $1.75B | $1.59B | $1.20B | $1.50B | $1.28B | $1.58B | $1.50B | $1.70B |
| Capital expenditures | $268.30M | $331.20M | $597.30M | $264.60M | $87.70M | $113.80M | $114.70M | $100.00M | $144.90M | $167.70M | $184.70M | $156.00M | $162.70M | $404.70M | $117.90M | $152.00M | $187.90M | $394.50M | $356.80M | $224.50M |
| Depreciation | $197.40M | $230.00M | $275.10M | $337.40M | $340.20M | $359.90M | $363.10M | $358.50M | $375.80M | $712.40M | $1.04B | $1.06B | $1.04B | $1.01B | $1.03B | $937.70M | $926.40M | $951.70M | $996.30M | $1.09B |
| Stock-based comp | — | — | $69.90M | $75.30M | $62.00M | $60.50M | $55.00M | $48.50M | $49.40M | $46.40M | $57.30M | $53.70M | $65.50M | $84.30M | $79.70M | $76.00M | $105.00M | $99.80M | $101.00M | $90.20M |
| Free cash flow | $772.40M | $753.20M | $440.80M | $852.90M | $1.11B | $1.06B | $1.04B | $863.10M | $915.60M | $682.10M | $1.45B | $1.43B | $1.58B | $1.18B | $1.09B | $1.35B | $1.10B | $1.19B | $1.14B | $1.47B |
| Investing cash flow | $-287.00M | $-491.50M | $-924.20M | $-381.20M | $-726.90M | $-624.40M | $-592.10M | $-282.50M | $-469.40M | $-7.56B | $-1.69B | $-510.80M | $-416.60M | $-729.30M | $-613.80M | $-503.60M | $-529.20M | $-778.90M | $-888.10M | $-1.98B |
| Financing cash flow | $-730.70M | $-399.50M | $-343.50M | $-262.10M | $-489.60M | $-455.80M | $-436.50M | $-467.30M | $-562.40M | $7.14B | $-743.20M | $-1.21B | $-1.30B | $-779.90M | $-421.80M | $-1.31B | $-843.80M | $-763.50M | $-484.50M | $326.00M |
| Dividends paid | — | — | — | $0.00 | $0.00 | $510.40M | $94.40M | $132.40M | $145.50M | $157.10M | $188.40M | $193.60M | $195.20M | $196.70M | $198.50M | $200.10M | $201.20M | $200.90M | $196.00M | $190.30M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $479.10M | $-22.80M | $99.40M | $116.00M | $196.30M | $2.70M | $376.00M | $-825.20M | $-109.70M | $28.60M | $76.60M | $168.90M | $-310.40M | $58.50M | — | — | — |